COMMUNIQUÉS West-GlobeNewswire

Orion Corporation: Managers’ transactions – Virve Laitinen
04/03/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion Corporation: Managers’ transactions – Virve Laitinen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Orion Corporation: Managers’ transactions – Niclas Lindstedt
04/03/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion Corporation: Managers’ transactions – Niclas Lindstedt Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) [...]
RadNet, Inc. to Present at the Raymond James 45th Annual Institutional Investors Conference Today, March 4th, 2024
04/03/2024
LOS ANGELES, March 04, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
Orion Corporation: Managers’ transactions – Hao Pan
04/03/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion Corporation: Managers’ transactions – Hao Pan Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/ [...]
Orion Corporation: Managers’ transactions – Outi Vaarala
04/03/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion Corporation: Managers’ transactions – Outi Vaarala Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair
04/03/2024
CytoMed diversifies into regenerative medicine SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on [...]
Transactions in connection with share buy-back program
04/03/2024
Company Announcement COPENHAGEN, Denmark; March 4, 2024 – Genmab A/S (Nasdaq: GMAB). On February 14, 2024, Genmab announced the initiation of a share buy-back program to honor our commitments under our Restricted Stock [...]
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
04/03/2024
- BridgeBio grants Bayer exclusive license to commercialize acoramidis as a treatment for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) in Europe - BridgeBio to receive royalties according to a tiered [...]
Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)
04/03/2024
Oslo, Norway, 4 March 2024 Vistin Pharma has aquired a 15% share in CF Pharma Kft. CF Pharma is an API CDMO located in Budapest, Hungary with a broad customer base of recognized international pharmaceutical companies. [...]
Andrew Fisher Joins Verona Pharma as General Counsel
04/03/2024
LONDON and RALEIGH, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces Mr. Andrew Fisher has today joined the Company as General Counsel, and member [...]
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo
04/03/2024
Planegg/Martinsried, March 4, 2024. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today [...]
BioVie Inc. Announces Pricing of Public Offering
04/03/2024
CARSON CITY, Nev., March 04, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]
Novartis presents new data on safety and efficacy of Zolgensma, including maintained and improved motor milestones in older and heavier children with SMA
04/03/2024
The SMART study supplements a growing body of evidence on the use of Zolgensma in a patient population older and heavier (1.5 – 9.1 years of age) than the children treated in previous clinical studies 1-6 Nearly all [...]
Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease
04/03/2024
Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer ’ s Disease VIVIAD Phase 2b study did not meet its primary and key secondary endpoints Varoglutamstat was [...]
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
04/03/2024
Saint-Herblain (France), March 4, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will participate at upcoming investor conferences in the [...]
Valneva fera une présentation lors des conférences investisseurs TD Cowen et Van Lanschot Kempen
04/03/2024
Saint-Herblain (France), 4 mars 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui que des membres de son équipe dirigeante participeront à des conférences [...]
Coherus Completes Divestiture of Ophthalmology Franchise
04/03/2024
– Upfront cash payment of $170 million strengthens capital structure – – Transaction solidifies Coherus’ strategic focus in oncology – REDWOOD CITY, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. ( [...]
Sandoz acquires CIMERLI® business from Coherus, further building biosimilar and ophthalmology leadership in US market
04/03/2024
MEDIA RELEASE CIMERLI ® *, a ranibizumab biosimilar, is interchangeable with LUCENTIS ® ** (ranibizumab injection) for all approved indications Dedicated retina sales and field reimbursement team integrated into Sandoz [...]
Ibogaine By David Dardashti Announces Breakthrough Algorithm to Quantify Quantum Electrodynamics
03/03/2024
Unlocking a Comprehensive Understanding of the Electric Force MIAMI, March 03, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a leading technology platform, is pleased to announce the successful development of an [...]

Pages